miRNA therapeutics

At the Rodman & Renshaw Healthcare Conference in New York this Week, a company official noted that in work conducted with Mirna Therapeutics, Marina found a 100-fold increase in microRNA in three different tissues, along with downregulation of the intended gene targets.

The company has exclusively licensed inventions related to the modulation of miR-146 and miR-155, key mediators of the inflammatory response.

People in the News

Premium

Chris Earl, Corey Goodman, Evan Melrose

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.